Genentech reiterated by Merrill at buy

Genentech Inc. was reiterated by Merrill Lynch analyst Eric Ende at a buy rating with a price target on the stock of $103 per share. Merrill said recent weakness in the stock price is a buying opportunity. Genentech shares Tuesday were down $2.69, or 3.26%, at $79.86 on volume of 8,387,200 shares versus the three-month running average of 3,648,060 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.